Orlando Health Welcomes Florida Medical Clinic
August 01, 2023 13:42 ET
|
Florida Medical Clinic
ORLANDO, Fla., Aug. 01, 2023 (GLOBE NEWSWIRE) -- Effective today, Orlando Health announces its expansion into Hillsborough and Pasco counties by joining forces with Florida Medical Clinic (FMC). FMC...
Breaking Into a Saturated Relapsing Remitting Multiple Sclerosis Market: Where Should Developers Focus?
August 01, 2023 12:02 ET
|
Spherix Global Insights
Exton, Pennsylvania, Aug. 01, 2023 (GLOBE NEWSWIRE) -- Despite outward appearances of being a stagnant market, the relapsing remitting multiple sclerosis (RMS) market continues to offer drug...
China Medical System Once Again Received MSCI-ESG 'AA' Rating, Leading the Industry in ESG Management
July 31, 2023 08:00 ET
|
China Medical System Holdings Ltd.
SHENZHEN, CHINA, July 31, 2023 (GLOBE NEWSWIRE) -- Recently, MSCI (Morgan Stanley Capital International), the world's largest index company, announced the latest Environmental, Social, and...
First-to-Market Edge for Apellis’s Syfovre in Geographic Atrophy Diminished in the Face of an Unexpected Safety Signal
July 28, 2023 12:26 ET
|
Spherix Global Insights
Exton, Pennsylvania, July 28, 2023 (GLOBE NEWSWIRE) -- For many who have been following the retina market, the news about the emerging safety signal associated with Apellis’ Syfovre in geographic...
Asia-Pacific Plasma Therapy Market to be Worth $214 Million by 2030 - Exclusive Report by Meticulous Research®
July 27, 2023 18:00 ET
|
Meticulous Market Research Pvt. Ltd.
Redding, California, July 27, 2023 (GLOBE NEWSWIRE) -- According to a new market research report, ‘Asia-Pacific Plasma Therapy Market, By Type (Pure Platelet-rich Plasma, Platelet-rich Fibrin),...
Iridex to Report Second Quarter Financial Results on August 10, 2023
July 27, 2023 16:05 ET
|
IRIDEX Corporation
MOUNTAIN VIEW, Calif., July 27, 2023 (GLOBE NEWSWIRE) -- Iridex Corporation (NASDAQ: IRIX), a provider of innovative ophthalmic laser-based medical products for the treatment of glaucoma and retinal...
Market Access Issues Hindering Specialists’ Use of Advanced Systemics in Lupus Nephritis
July 27, 2023 16:00 ET
|
Spherix Global Insights
Exton, Pennsylvania, July 27, 2023 (GLOBE NEWSWIRE) -- While the approvals of GSK’s Benlysta (belimumab) and Aurinia’s Lupkynis (voclosporin) have provided rheumatologists and nephrologists with...
Kriya Announces $150 Million Addition to its Series C, Bringing Total Round to over $430 Million to Further its Mission of Delivering Gene Therapies for Prevalent Diseases
July 26, 2023 08:25 ET
|
Kriya Therapeutics, Inc.
– Kriya's therapeutic pipeline addresses a broad range of diseases that collectively affect millions of patients worldwide—with a goal of delivering transformational clinical benefits with one-time...
Bloomage Biotech Ushers in a New Era of Sustainability with Launch of ESG Strategic Management Center
July 25, 2023 09:00 ET
|
Bloomage BioTechnology Corporation Limited
Parsippany, New Jersey, US, July 25, 2023 (GLOBE NEWSWIRE) -- Bloomage Biotech, a world-leading biotechnology and biomaterials company specializing in hyaluronic acid, is excited to announce the...
FDA Approves XDEMVY™ (lotilaner ophthalmic solution) 0.25% for the treatment of Demodex blepharitis
July 25, 2023 07:00 ET
|
Tarsus Pharmaceuticals, Inc
XDEMVY is the first and only approved therapeutic for Demodex blepharitis, a highly prevalent eyelid disease that impacts approximately 25 million eye care patients in the U.S. XDEMVY targets the...